Outcome of lung cancer according to primary treatment - a health care research study using data cancer registry data (registration according to § 65c SGB V)
Recruiting
- Conditions
- C34Malignant neoplasm of bronchus and lung
- Registration Number
- DRKS00028698
- Lead Sponsor
- niversität zu Lübeck, Institut für Sozialmedizin und Epidemiologie
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 60000
Inclusion Criteria
ICD-10 C34; Place of residence in federal state of respective cancer registry
Exclusion Criteria
DCO case
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Population-based description of the outcome of lung cancer according to primary treatment in Germany. We will use data of the clinical cancer registration according to § 65c SGB V (mandatory notification of diagnosis, treatment and follow up of cancer patients).<br>Primary endpoint: observed 5-year-overall survival
- Secondary Outcome Measures
Name Time Method 1.) progression-free survival<br>2.) in the subcohort of individuals with oligometastatic disease: overall survival and progression-free survival